Variation of Psychopharmacological Prescription Rates for People With Autism Spectrum Disorder (ASD) in 30 Countries
This study investigated psychopharmacological treatment patterns for Autism Spectrum Disorder (ASD) comorbidities in 30 countries and the association between country's income and prescription rates. The IMS Prescribing Insights database was used to investigate prescription patterns for ASD comorbidity treatment from 2007 to 2012. Data were obtained from 12 European countries (Austria, Belgium, the Netherlands, Finland, Ireland, Switzerland, Greece, Czech Republic, Hungary, Poland, Portugal, and Slovakia), six Asian countries (South Korea, Thailand, Indonesia, Pakistan, Turkey, and Saudi Arabia), two South American countries (Colombia and Venezuela), two countries in Oceania (Australia and New Zealand), and two African countries (Egypt and South Africa). The gross domestic product (GDP) per capita was used as a proxy for each country's income.
Study design
Cohort
Number of participants at first data collection
No information available
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
Practitioner prescriptions in each country included.
Sample features
Countries
Year of first data collection
2007
Primary Institutions
King's College London (KCL)
Radboud University Nijmegen (Radboud Universiteit)
University College London (UCL)
University of Hong Kong (香港大學, HKU)
Links
No website available
Profile paper DOI
Funders
European Autism Interventions (EU-AIMS)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Ongoing?
No
Data types collected
- Secondary data
- None
- None
- Healthcare data
Engagement
Keywords
